MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD ...

MIRA Pharmaceuticals (MIRA) announced results demonstrating that its oral drug candidate Ketamir-2 restored normalized behavior in stressed animals within a validated model of post-traumatic stress ...

Autism assessment still often leaves lived experience unheard and unseen by focusing almost exclusively on outwardly observable behaviours.